Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-25-019632

CFO & Head of Corp Development acquired 147,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ghias Babar · CFO & Head of Corp Development

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-24 Grant or award : show line 1 in the form +147,000 147,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-24 Grant or award : show line 2 in the form Emp. Stock Option (Right to Buy) +305,000 305,000 D
Loading xslF345X05/form4.xml…